Risk aversion and COVID‐19 vaccine hesitancy - HAL-SHS - Sciences de l'Homme et de la Société Accéder directement au contenu
Article Dans Une Revue Health Economics Année : 2023

Risk aversion and COVID‐19 vaccine hesitancy

Anthony Lepinteur
  • Fonction : Auteur
  • PersonId : 1092408
Liyousew Borga
Claus Vögele
Conchita D’ambrosio

Résumé

We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.

Dates et versions

halshs-04206111 , version 1 (13-09-2023)

Licence

Identifiants

Citer

Anthony Lepinteur, Liyousew Borga, Andrew E. Clark, Claus Vögele, Conchita D’ambrosio. Risk aversion and COVID‐19 vaccine hesitancy. Health Economics, 2023, 32 (8), pp.1659-1669. ⟨10.1002/hec.4693⟩. ⟨halshs-04206111⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More